Startseite
News
Tech
Finanzbranche
Leadership
Well
Recommends
Fortune 500
Home Page
Already have an account?
SIGN IN
SEARCH
Subscribe Now
Sections
FORTUNE 500
News
Europa
Asia
Tech
AI
Finanzbranche
Personal Finance
Immobilien
Crypto
Leadership
Success
Well
Leben
Health
Mind
Family
Aging Well
Recommends
Credit Cards
Banking
Best High-Yield Savings Accounts
Best Savings Accounts
Best CD Rates
Best Money Market Accounts
Savings Calculator
Insurance
Mortgages
Investing
Loans
Health
Bildung
Top Business Schools
Top Information Technology and Data Schools
Top Health Schools
Business Solutions
Video
Rankings
FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS
Analytics
Newsletters
Magazine
December 2023/January 2024
October/November 2023
August/September 2023
June/July 2023
April/May 2023
February/March 2023
Live Media
CEO Initiative
Robert Langreth
Health
Ozempic linked to rare cases of vision loss in Harvard study
BY
Robert Langreth
and
Bloomberg
Health
Lilly wins FDA approval for new drug to slow Alzheimer’s
BY
Madison Muller
,
Robert Langreth
, and others
Politics
‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture
BY
Madison Muller
,
Robert Langreth
, and others
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
BY
Madison Muller
,
Robert Langreth
, and others
Health
Moderna’s updated COVID vaccine helps fight against a new strain, study shows, and may be approved for use as soon as Friday
BY
Robert Langreth
and
Bloomberg
Health
Moderna’s Omicron vaccine produces antibodies against new variants, new trial shows
BY
Robert Langreth
and
Bloomberg
Health
Moderna says its Omicron-specific vaccine boosts antibodies in new trial
BY
Robert Langreth
and
Bloomberg
Health
New prescription drug prices soared to $180,000 a year on 20% annual inflation in 2021, study finds
BY
Robert Langreth
and
Bloomberg
Health
Pfizer says a third vaccine dose boosts antibodies against Omicron in kids 5 to 11
BY
Robert Langreth
and
Bloomberg
Health
Almost all teens needing ICU care for COVID are unvaccinated
BY
Robert Langreth
and
Bloomberg
Health
FDA set to authorize Pfizer and Merck COVID pills this week
BY
Josh Wingrove
,
Jennifer Jacobs
, and others
Health
Pfizer: COVID vaccine is 91% effective in kids ages 5 to 11
BY
Robert Langreth
and
Bloomberg
Health
Pfizer submits request to authorize COVID vaccine for kids to FDA
BY
Robert Langreth
,
Catherine Larkin
, and others
Health
Two recent studies help explain breakthrough infections in those with two COVID-19 vaccine doses
BY
Alisa Odenheimer
,
Robert Langreth
, and others
Health
J&J says COVID booster dose provides 100% protection against severe disease
BY
Robert Langreth
and
Bloomberg
Load More